Back
Alnylam Pharmaceuticals Stock Price Chart
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject
Buy
51
ALNY
Alnylam Pharmaceuticals
Last Price:
242.97
Seasonality Move:
20.36%
7 Day Trial
ALL ACCESS PASS
$
7
What's Nvidia doing next??
Click here now to learn more about Nvidia's next AI move.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight selling pressure.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 209.44 | Buy |
| 20-day SMA: | 176.25 | Buy |
| 50-day SMA: | 159.62 | Buy |
| 200-day SMA: | 165.96 | Buy |
| 8-day EMA: | 218.01 | Buy |
| 20-day EMA: | 188.75 | Buy |
| 50-day EMA: | 168.9 | Buy |
| 200-day EMA: | 168.09 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 22.91 | Buy |
| Relative Strength Index (14 RSI): | 86.77 | Buy |
| Chaikin Money Flow: | -1210062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (135.8 - 205.74) | Buy |
| Bollinger Bands (100): | (136.44 - 176.64) | Buy |
Alnylam Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 243.08 while ALNY 8-day simple moving average is 209.44, which is a Buy signal.
- The stock price of ALNY is 243.08 while Alnylam Pharmaceuticals 20-day SMA is 176.25, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day simple moving average is 159.62 while ALNY share price is 243.08, making it a Buy technically.
- ALNY stock price is 243.08 and Alnylam Pharmaceuticals 200-day simple moving average is 165.96, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Buy
The current Alnylam Pharmaceuticals [ALNY] share price is $243.08. The Score for ALNY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
30.75B
Price in USD:
243.08
Share Volume:
2.42M
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
252.87
52-Week Low:
141.98
Buy
51
Alnylam Pharmaceuticals (ALNY)
is a Buy
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 243.08 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is not overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 243.08 while ALNY 8-day exponential moving average is 218.01, which is a Buy signal.
- The stock price of ALNY is 243.08 while Alnylam Pharmaceuticals 20-day EMA is 188.75, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day exponential moving average is 168.90 while ALNY share price is 243.08, making it a Buy technically.
- ALNY stock price is 243.08 and Alnylam Pharmaceuticals 200-day simple moving average is 168.09, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.12 per share, a decrease this year of $0.46 per share, and an increase next year of $1.83 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is 22.91, suggesting Alnylam Pharmaceuticals is a Buy
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 86.77, which suggest Alnylam Pharmaceuticals is overbought
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (135.8 - 205.74), which suggest Alnylam Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (136.44 - 176.64), which suggest Alnylam Pharmaceuticals is a Buy
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.